CerFlux is a health technology company which develops and markets tools to help visualize and predict the efficacy if individualized cancer treatments. It was founded in 2018 and is headed by CEO Karim Budhwani. Its offices are located in the Park Building at 2140 11th Avenue South, with a research laboratory in the Family Reserve Insurance building at 600 20th Street North.
- Patchen, Tyler (July 18, 2019) "New biotech and R&D space set to open downtown." Birmingham Business Journal
- Patchen, Tyler (September 15, 2020) "CerFlux receives grant for development of oncology test." Birmingham Business Journal
- Patchen, Tyler (January 5, 2021) "CerFlux raises $1 million in seed capital." Birmingham Business Journal
- CerFlux website